IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Psycheceutical Bioscience (BWVI)

CUSIP: 09609E105 | NYSE | 1 institutional holders

Quarters

Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

Summit Global Investments250,000
0.0% of portfolio›$62
StyleTurnoverLocationFiled
Summit Global Investments
250,000$620.0%CoreMediumBountiful, UT2018-11-15